Early Cancer detection, Cancer cure using CrispR and Genomics, Holistic health.

Anthill has strong interest in investing in, and advising, early stage companies in areas like early cancer detection, cancer cure using next-gen technologies like Genomics sequencing and CRISPR, holistic health with Ayurveda and other alternatives, and adjacencies like wound and trauma management.

Our partnerships with HCG, and numerous other premier Healthcare providers enable us to provide tremendously useful advisors, access to mentors, and business development opportunities – all designed to precipitate rapid growth!

4000 +


10M +

Healthcare patients

Anthill gives a wonderful pulse into the health tech startups ecosystem globally. Aligning with them has helped us discover and interact with numerous early stage companies with high pedigree and strong IP. The solutions from these companies often complement our offerings and as such, are a great benefit to HCG

Anjali Ajaikumar

VP of Strategy, HCG



Ms. Madhavi Kanumoory

CIO - HealthCare Global Enterprises Ltd

Dr Chandrika Kambam

Director, Clinical Services - HealthCare Global Enterprises Ltd

Dr Vishal Rao

Chief of Surgical oncology & Robotic surgery - HealthCare Global Enterprises Ltd

Dr Veena R

Consultant Pathologist

Dr Radheshyam Naik

Pioneer in the field of Medical Oncology

Dr Mithua Ghosh

Head of Department - Molecular and Clinical Genomics at Strand Life Sciences

Mr. Venkatesan



Visual Portfolio, Posts & Image Gallery for WordPress
Scroll to top